Gastroesophageal reflux disease (GERD)
Gastroesophageal reflux disease (GERD) can cause respiratory symptoms and exacerbate lung disorders. Managing GERD is essential for preventing respiratory complications and optimizing lung function.
Gastroesophageal reflux disease (GERD) can impair pulmonary function, exacerbating lung disorders. Symptoms include heartburn and regurgitation. GERD may worsen conditions like asthma, pulmonary fibrosis, and obstructive sleep apnea. Managing GERD is vital for preventing respiratory complications and optimizing lung function.
Related Conference of Gastroesophageal reflux disease (GERD)
September 23-24, 2024
15th International Conference on Pulmonary & Respiratory Medicine
Singapore City, Singapore
October 24-25, 2024
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
Gastroesophageal reflux disease (GERD) Conference Speakers
Recommended Sessions
- Asthma
- Atelectasis and Pneumothorax
- Cardiopulmonary Disease
- Chronic Obstructive Pulmonary Disease (COPD)
- Climate Change and Respiratory Diseases
- Epidemiology of TB Disease
- Gastroesophageal reflux disease (GERD)
- Latent TB Infection and Active TB Disease
- Lung Cancer: Screening, Diagnosis & Treatment
- Lung Function in Men with and without HIV
- Lung Infection
- Multidrug-resistant TB
- Mycobacterial Infections
- Palliative Care for Advanced Lung Cancer
- Pulmonary Complications of Endocrine Diseases
- Pulmonary Diseases and Therapeutics
- Pulmonary Edema
- TB Clinical Trials
- TB Diagnosis, Prevention & Treatment
- TB Vaccines
- TB-HIV Co-infections
- Zoonotic TB
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)